Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this trial is to compare an individually optimized dose of the lisuride TTS
patch against placebo and against an individually optimized dose of oral ropinirole (active-
and placebo-controlled design) in idiopathic and uremic RLS patients with regard to efficacy,
safety, and quality of life.